| Group/s |
Renal sFlt-1 |
Renal VEGF |
Serum sFlt-1(pg/ul) |
Serum PlGF(pg/ul) |
| Pregnant control |
0.73 ± 0.01 |
1.53 ± 0.04 |
0.21 ± 0.09 |
1.36 ± 0.05 |
| Early-onset PE |
1.34 ± 0.05*** |
1.03 ± 0.01*** |
1.30 ± 0.05*** |
0.37 ± 0.01*** |
| Early-onset PE (SC) |
1.03 ± 0.01 |
1.16 ± 0.01 |
1.02 ± 0.02 |
0.90 ± 0.05 |
| Late-onset PE |
1.46 ± 0.04*** |
1.02 ± 0.03*** |
1.46 ± 0.05*** |
0.38 ± 0.01*** |
| Late-onset PE (SC) |
1.02 ± 0.04 |
1.48 ± 0.06 |
1.02 ± 0.02 |
0.92 ± 0.06 |
| *** Significant difference p < 0.01 when compared to pregnant control |
|
